BACKGROUND: Detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has principally been performed through the use of real-time reverse-transcription polymerase chain reaction testing. Results of such tests can be reported as cycle threshold (Ct) values, which may provide semi-quantitative or indirect measurements of viral load. Previous reports have examined temporal trends in Ct values over the course of a SARS-CoV-2 infection. METHODS: Using testing data collected during a prospective household transmission investigation of outpatient and mild coronavirus disease 2019 cases, we examined the relationships between Ct values of the viral RNA N1 target and demographic, clinical, and epidemiological characteristics collected through participant interviews and daily symptom diaries. RESULTS: We found that Ct values are lowest (corresponding to a higher viral RNA concentration) soon after symptom onset and are significantly correlated with the time elapsed since onset (P < .001); within 7 days after symptom onset, the median Ct value was 26.5, compared with a median Ct value of 35.0 occurring 21 days after onset. Ct values were significantly lower among participants under 18 years of age (P = .01) and those reporting upper respiratory symptoms at the time of sample collection (P = .001), and were higher among participants reporting no symptoms (P = .05). CONCLUSIONS: These results emphasize the importance of early testing for SARS-CoV-2 among individuals with symptoms of respiratory illness, and allow cases to be identified and isolated when their viral shedding may be highest. Published by Oxford University Press for the Infectious Diseases Society of America 2020.
BACKGROUND: Detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has principally been performed through the use of real-time reverse-transcription polymerase chain reaction testing. Results of such tests can be reported as cycle threshold (Ct) values, which may provide semi-quantitative or indirect measurements of viral load. Previous reports have examined temporal trends in Ct values over the course of a SARS-CoV-2 infection. METHODS: Using testing data collected during a prospective household transmission investigation of outpatient and mild coronavirus disease 2019 cases, we examined the relationships between Ct values of the viral RNA N1 target and demographic, clinical, and epidemiological characteristics collected through participant interviews and daily symptom diaries. RESULTS: We found that Ct values are lowest (corresponding to a higher viral RNA concentration) soon after symptom onset and are significantly correlated with the time elapsed since onset (P < .001); within 7 days after symptom onset, the median Ct value was 26.5, compared with a median Ct value of 35.0 occurring 21 days after onset. Ct values were significantly lower among participants under 18 years of age (P = .01) and those reporting upper respiratory symptoms at the time of sample collection (P = .001), and were higher among participants reporting no symptoms (P = .05). CONCLUSIONS: These results emphasize the importance of early testing for SARS-CoV-2 among individuals with symptoms of respiratory illness, and allow cases to be identified and isolated when their viral shedding may be highest. Published by Oxford University Press for the Infectious Diseases Society of America 2020.
Authors: Laura Ford; Melissa J Whaley; Melisa M Shah; Phillip P Salvatore; Hannah E Segaloff; Augustina Delaney; Dustin W Currie; Lauren Boyle-Estheimer; Michelle O'Hegarty; Clint N Morgan; Jennifer Meece; Lynn Ivacic; Natalie J Thornburg; Azaibi Tamin; Jennifer L Harcourt; Jennifer M Folster; Magdalena Medrzycki; Shilpi Jain; Phili Wong; Kimberly Goffard; Douglas Gieryn; Juliana Kahrs; Kimberly Langolf; Tara Zochert; Jacqueline E Tate; Christopher H Hsu; Hannah L Kirking Journal: J Pediatric Infect Dis Soc Date: 2021-12-31 Impact factor: 3.164
Authors: Beatrice Casati; Joseph Peter Verdi; Alexander Hempelmann; Maximilian Kittel; Andrea Gutierrez Klaebisch; Bianca Meister; Sybille Welker; Sonal Asthana; Salvatore Di Giorgio; Pavle Boskovic; Ka Hou Man; Meike Schopp; Paul Adrian Ginno; Bernhard Radlwimmer; Charles Erec Stebbins; Thomas Miethke; Fotini Nina Papavasiliou; Riccardo Pecori Journal: Nat Commun Date: 2022-06-08 Impact factor: 17.694
Authors: Kevin Escandón; Angela L Rasmussen; Isaac I Bogoch; Eleanor J Murray; Karina Escandón; Saskia V Popescu; Jason Kindrachuk Journal: BMC Infect Dis Date: 2021-07-27 Impact factor: 3.090
Authors: Erin Chung; Eric J Chow; Naomi C Wilcox; Roy Burstein; Elisabeth Brandstetter; Peter D Han; Kairsten Fay; Brian Pfau; Amanda Adler; Kirsten Lacombe; Christina M Lockwood; Timothy M Uyeki; Jay Shendure; Jeffrey S Duchin; Mark J Rieder; Deborah A Nickerson; Michael Boeckh; Michael Famulare; James P Hughes; Lea M Starita; Trevor Bedford; Janet A Englund; Helen Y Chu Journal: JAMA Pediatr Date: 2021-10-04 Impact factor: 26.796